Search: adjuvant
Résultats de recherche
Search in
Filter by
144 results
Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database
- By Stephane Dalle,
- Emilie Varey,
- Jean-Michel Nguyen,
- et al.
In European Journal of Dermatology (2020/4 Vol. 30)
…Management of adjuvant settings for Stage III melanoma patients in France prior to…
…Management of adjuvant settings for Stage III melanoma patients in France prior to…
Adjuvant treatment decisions of patients with stage IIB/C and III melanoma in routine clinical practice
- By Norma Mechow,
- Wiebke K. Peitsch,
- Katharina Diehl,
- et al.
In European Journal of Dermatology (2024/6 Vol. 34)
…Adjuvant treatment decisions of patients with stage IIB/C and III…
…Adjuvant treatment decisions of patients with stage IIB/C and III…
Which selection criteria and which adjuvant chemotherapy regimen should be adopted following colon cancer resection?
In Hépato-Gastro & Oncologie Digestive (2023/3 Vol. 30)
…Which selection criteria and which adjuvant chemotherapy regimen should be adopted following colon cancer resection? Audrey…
…Which selection criteria and which adjuvant chemotherapy regimen should be adopted following colon cancer resection? Audrey…
The effect of adjuvant treatments on the risk of developing metastases after nephrectomy in patients with localized kidney cancer based on trials in 2022
- By Florian Carneiro,
- Cécilia Leger,
- Romaine Ing,
- et al.
In Innovations & Thérapeutiques en Oncologie (2023/2 Volume 9)
The effect of adjuvant treatments on the risk of developing metastases after nephrectomy in…
The effect of adjuvant treatments on the risk of developing metastases after nephrectomy in…
Neo-adjuvant treatment of colon cancer: Toward a personalized approach
- By Émilie Hafliger,
- Antoine Cazelles,
- Mehdi Karoui
- et al.
In Hépato-Gastro & Oncologie Digestive (2024/6 Vol. 31)
…Neo-adjuvant treatment of colon cancer: Toward a personalized approach The standard…
…Neo-adjuvant treatment of colon cancer: Toward a personalized approach The standard…
Biliary tract cancers: A focus on adjuvant strategies
- By Marie Muller
- and Cindy Neuzillet
In Hépato-Gastro & Oncologie Digestive (2023/10 Vol. 30)
…Biliary tract cancers: A focus on adjuvant strategies In France, biliary tract cancers (BTCs) account for 15…
…Biliary tract cancers: A focus on adjuvant strategies In France, biliary tract cancers (BTCs) account for 15…
Early HR+ HER2- breast cancers: State-of- the art
Innovations & Thérapeutiques en Oncologie (2023/Special Issue 1 Volume 9)Successful adjuvant nivolumab therapy in a toddler with xeroderma pigmentosum and stage III melanoma
- By Liliane Borik-Heil,
- Christoph Höller,
- Kornelia Böhler,
- et al.
In European Journal of Dermatology (2025/6 Vol. 35)
Successful adjuvant nivolumab therapy in a toddler with xeroderma pigmentosum and stage…
Successful adjuvant nivolumab therapy in a toddler with xeroderma pigmentosum and stage…
Fertility preservation strategies among young women with breast cancer before adjuvant or neoadjuvant chemotherapy
- By Céleste Becquart
- and Michaël Grynberg
In Médecine de la Reproduction (2025/3 Vol. 27)
…Fertility preservation strategies among young women with breast cancer before adjuvant or neoadjuvant chemotherapy Breast cancer is one of the most…
…Fertility preservation strategies among young women with breast cancer before adjuvant or neoadjuvant chemotherapy Breast cancer is one of the most…
Clinical data on CDK4/6 inhibitors and breast cancer: From metastatic to adjuvant treatment
- By Marc Espié
In Innovations & Thérapeutiques en Oncologie (2022/3 Volume 8)
…on CDK4/6 inhibitors and breast cancer: From metastatic to adjuvant treatment The combination of hormone therapy and CDK4/6 inhibitors…
…on CDK4/6 inhibitors and breast cancer: From metastatic to adjuvant treatment The combination of hormone therapy and CDK4/6 inhibitors…
What role will adjuvant immunotherapy play in the treatment of localized renal cancer in 2024?
In Innovations & Thérapeutiques en Oncologie (2024/Special Issue 1 Volume 10)
What role will adjuvant immunotherapy play in the treatment of localized renal cancer in…
What role will adjuvant immunotherapy play in the treatment of localized renal cancer in…
Adjuvant chemotherapy after surgical resection of pancreatic adenocarcinoma: Age is not a limitation
In Hépato-Gastro & Oncologie Digestive (2022/5 Vol. 29)
…Adjuvant chemotherapy after surgical resection of pancreatic adenocarcinoma: Age is not…
…Adjuvant chemotherapy after surgical resection of pancreatic adenocarcinoma: Age is not…
Outcomes among patients with infantile spasms treated with hormonal therapy and adjuvant topiramate versus hormonal therapy alone
- By Jordana R. Fox,
- Natalie Guido-Estrada,
- Korwyn Williams
- et al.
In Epileptic Disorders (2020/1 Vol 22)
…among patients with infantile spasms treated with hormonal therapy and adjuvant topiramate versus hormonal therapy alone Jordana R. Fox Department of…
…among patients with infantile spasms treated with hormonal therapy and adjuvant topiramate versus hormonal therapy alone Jordana R. Fox Department of…
Journal Club: Current state of neoadjuvant therapy for melanoma
- By Simon Goller,
- Luis Jiménez-Briones,
- Belén Rodríguez Sánchez,
- et al.
In European Journal of Dermatology (2026/1 Vol. 36)
…are on their way to displacing upfront surgery followed by adjuvant therapy as standard of care. This review synthesizes the rationale, pros and cons of adjuvant versus neoadjuvant therapy, preclinical evidence, and pioneering early studies on…
…are on their way to displacing upfront surgery followed by adjuvant therapy as standard of care. This review synthesizes the rationale, pros and cons of adjuvant versus neoadjuvant therapy, preclinical evidence, and pioneering early studies on…
Clinical and pathological evaluation of cladribine treatment response in a case series of patients with xanthoma disseminatum
- By Eray Yihui Zhou,
- Fan Yu,
- Yanying Wang,
- et al.
In European Journal of Dermatology (2023/3 Vol. 33)
…disease involvement of the relative organs was suspected. Chemotherapy and adjuvant treatments 6 Cladribine was administered by a two-hour intravenous…
…disease involvement of the relative organs was suspected. Chemotherapy and adjuvant treatments 6 Cladribine was administered by a two-hour intravenous…
Rehabilitation of post-stroke aphasia: Approach 2.0
In Revue de neuropsychologie (2022/2 Volume 14)
…have significant communication difficulties despite participation in SLT. In response, adjuvant therapies to SLT, like pharmacotherapy, non-invasive brain stimulation, virtual…
…have significant communication difficulties despite participation in SLT. In response, adjuvant therapies to SLT, like pharmacotherapy, non-invasive brain stimulation, virtual…
Home anti-PD1 immunotherapy for melanoma: results of a patient and nursing satisfaction survey
- By Thu Thao Truong,
- Marie Lapassat,
- Aude Belbezier,
- et al.
In European Journal of Dermatology (2025/1 Vol. 35)
…months [4, 5]. Three ICIs have been used routinely as adjuvant or first-line therapy: ipilimumab (an anti-CTLA4 antibody [5…
…months [4, 5]. Three ICIs have been used routinely as adjuvant or first-line therapy: ipilimumab (an anti-CTLA4 antibody [5…
Nodular primary cutaneous melanoma is associated with PD-L1 expression
In European Journal of Dermatology (2020/4 Vol. 30)
…neoplastic cells had improved recurrence-free survival with anti-PD1 adjuvant therapy. Objectives: We examined PD-L1 expression as a possible…
…neoplastic cells had improved recurrence-free survival with anti-PD1 adjuvant therapy. Objectives: We examined PD-L1 expression as a possible…
Journal Club: Cutaneous squamous cell carcinoma
- By Angel Rosell Diaz,
- Marine-Alexia Lefevre,
- Sophia Mohme,
- et al.
In European Journal of Dermatology (2022/5 Vol. 32)
…the classification systems should be considered. 15 The use of adjuvant local radiotherapy in patients with high-risk SCC is widespread…
…the classification systems should be considered. 15 The use of adjuvant local radiotherapy in patients with high-risk SCC is widespread…
Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma
- By Clément Charpentier,
- Valéry-Pierre Riche,
- Jean-Michel Nguyen,
- et al.
In European Journal of Dermatology (2023/2 Vol. 33)
…2013 and December 2017 were included (NT group). Patients with adjuvant immunotherapy or targeted therapies were excluded. Furthermore, in 2013, the…
…2013 and December 2017 were included (NT group). Patients with adjuvant immunotherapy or targeted therapies were excluded. Furthermore, in 2013, the…
Pleomorphic dermal sarcoma: a retrospective study of 16 cases in a dermato-oncology centre and a review of the literature
- By Elisa Ríos-Viñuela,
- Carlos Serra-Guillén,
- Beatriz Llombart,
- et al.
In European Journal of Dermatology (2020/5 Vol. 30)
…treatment Subsequent treatments Number of modified MMS stages Negative margins Adjuvant therapy Subsequent outcomes Follow-up (months) 1 Primary Conventional surgery…
…treatment Subsequent treatments Number of modified MMS stages Negative margins Adjuvant therapy Subsequent outcomes Follow-up (months) 1 Primary Conventional surgery…
Effects of perioperative magnesium on postoperative analgesia following thoracic surgery: a meta-analysis of randomised controlled trials
- By Kuo-Chuan Hung,
- Sheng-Hsiang Yang,
- Shu-Wei Liao,
- et al.
In Magnesium Research (2023/4 Vol. 36)
…meta-analysis provides evidence supporting perioperative magnesium as an analgesic adjuvant at 24 hours following thoracic surgery, but no opioid-sparing…
…meta-analysis provides evidence supporting perioperative magnesium as an analgesic adjuvant at 24 hours following thoracic surgery, but no opioid-sparing…
Journal Club
- By Enrique Rodríguez-Lomba,
- Miguel Nogueira,
- Marine-Alexia Lefevre,
- et al.
In European Journal of Dermatology (2021/3 Vol. 31)
…19] or standard excision with wider margins, as well as adjuvant radiation or clinical trial enrolment [10]. Future studies and further…
…19] or standard excision with wider margins, as well as adjuvant radiation or clinical trial enrolment [10]. Future studies and further…
N-acetylcysteine: reinventing classic pharmacology through skin
In European Journal of Dermatology (2026/2 Vol. 36)
…profile, supports the use of topical NAC primarily as an adjuvant component in moderate to severe ichthyosis, particularly in patients refractory…
…profile, supports the use of topical NAC primarily as an adjuvant component in moderate to severe ichthyosis, particularly in patients refractory…
- 1